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Abstract
Aim: The aim of this study is to compare the short-term clinical outcomes between endoscopic submucosal dissection
and transanal local excision for rectal carcinoid tumors.
Methods: Between 2007 and 2012, 31 patients with rectal carcinoid underwent endoscopic submucosal dissection at
our hospital. They were compared with a matched cohort of 23 patients who underwent transanal local excision for
rectal carcinoid between 2007 and 2012. Short-term clinical outcomes including surgical parameters, postoperative
recovery, and oncologic outcomes were compared between the two groups.
Results: The mean size of tumors was significantly bigger in the transanal local excision group (0.8 ± 0.2 versus
1.1 ± 0.5 cm; P = 0.018). En bloc resection was achieved for 30 patients (97 %) in the endoscopic submucosal dissection
group and all the patients in the transanal local excision group. The operation time was longer in the transanal local
excision than that in the endoscopic submucosal dissection group (40.0 ± 22.7 min versus 12.2 ± 5.3 min; P < 0.001).
Complications in the transanal local excision group were five cases of acute retention of urine. There was no local
recurrence or distant metastasis in either group during the follow-up period.
Conclusion: For the treatment of rectal carcinoid tumors with diameter <1 cm, endoscopic submucosal dissection has
better short-term clinical outcomes than transanal local excision in terms of faster recovery and possibly a lower
morbidity rate. Transanal local excision may be the first therapeutic choice of scar-embedded rectal carcinoid
tumors.
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What does this paper add to the literature
statement?
In this work, we compare the short-term clinical out-
comes between endoscopic submucosal dissection (ESD)
and transanal local excision (TALE) for rectal carcinoid
tumors, so as to help surgeons decide which method
should be chosen for these patients.
Background
Rectal carcinoid tumors account for 18.5 % of all carcin-
oid tumors. Although these tumors represent only 1.3 %
of all rectal neoplasms, their incidence is drastically in-
creasing [1, 2]. These tumors can show a broad range of
clinical behavior, from benign and asymptomatic to dis-
seminated and metastatic [3]. Because rectal carcinoid
tumors often present as small and localized tumors that
rarely recur after resection, rectal carcinoid tumors have
the best prognosis among all carcinoid tumors with a 5-
year survival rate at 88.3 %, and thus have usually been
managed with local excision [4–6].
For rectal carcinoid tumors not amenable to conven-
tional colonoscopic removal, the alternative treatment op-
tion is TALE procedure. This local procedure has proved
to be safe and effective in the treatment of low rectal le-
sions. However, TALE approach must be performed with
the patient under anesthesia, such as spinal anesthesia,
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general endotracheal anesthesia (GETA), and IV sedation
+ local depending on tumor location and size, especially
the characteristics and comorbidities of patients.
ESD is a novel colonoscopic method that enables en
bloc resection for colorectal lesions. It can be performed
with patients without anesthesia. The ESD approach has
a reported perforation rate of 2 to 10 %, an en bloc re-
section rate of 80 to 90 %, and a short-term recurrence
rate for colorectal ESD of 0 to 2.1 % [7].
In the traditional sense, the indications of TALE for rec-
tal carcinoid tumors are as follows: (1) tumor located less
than 7 cm to anal edge, (2) tumor size accounted less than
1/3 lumen diameter, (3) tumor node metastasis (TNM)
staged earlier than T1. Except the above situation, choose
surgical oncologic resection. Despite a growing under-
standing of the clinical effectiveness of local excision for
small rectal carcinoid tumors, there is still controversy
concerning the best surgical choice for rectal carcinoid tu-
mors with different diameters [8]. The aim of this study is
to report our experiences of adopting two different local
excision procedures according to tumor diameter. To our
knowledge, there is no report about the surgical strategies
and results of ESD and TALE for rectal carcinoid tumors.
Methods
Patients and study design
Between October 2007 and December 2012, 78 patients
with rectal carcinoid were admitted to Changhai Hospital.
We included 54 patients in our study (31 patients under-
went ESD, 23 patients underwent TALE). The inclusion
criteria for TALE and ESD based upon tumor size, loca-
tion, and TNM stage: (1) tumor located less than 7 cm to
anal edge, (2) tumor size accounted less than 1/3 lumen
diameter, (3) TNM staged earlier than T1. Then, we ex-
cluded 24 patients who underwent surgical oncologic re-
section. The clinical data of patients with rectal carcinoid
who underwent either ESD or TALE were retrospectively
reviewed. In this study, we enrolled patients with rectal
carcinoid tumors that did not show regional lymph node
enlargement on computed tomography (CT) scanning or
endorectal ultrasonography (EUS) as previously reported
[9]. Patients underwent local excision using ESD or TALE.
All specimens were referred to pathologists and examined
microscopically for tumor size, depth of invasion, and re-
section margin status. The patients’ characteristics, opera-
tive details, pathological results, and short-term outcomes
were recorded. Six experienced, qualified surgeons and
endoscopists (En-da Yu, 30 years experience; Zheng Lou,
12 years experience; Rong-gui Meng, 32 years experience;
Wei Zhang, 25 years experience; Lian-jie Liu, 26 years
experience; Li-qiang Hao, 19 years experience, et al.) per-
formed the procedures (TALE and ESD).
Informed consent was obtained from all patients. The
study protocol conformed to the ethical guidelines of the
Helsinki Declaration. The ethical review has been ap-
proved by The Ethics Committee of Changhai Hospital.
Data and materials
TALE
In our study, all TALE procedures were performed with
the patient under spinal anesthesia, lithotomy position, or
clasp knife position. Anal retractors were first introduced
into the anal canal to maintain exposure. Normal saline
was injected into the submucosal plane with an injector
syringe to create a visible submucosal cushion for eleva-
tion of the lesion. The tumor then was excised with elec-
trocautery or an ultrasonic knife (Johnson) under direct
vision, performed in a submucosal resection, then the
wound was closed with absorbable sutures (Johnson). But,
one patient underwent additional surgery (TALE) after
ESD because the ESD specimen showed a positive resec-
tion margin, in a full thickness fashion.
ESD
In our center, we use a two-person approach to colonos-
copy. ESD was performed using a conventional endoscope
(CF-H260, Olympus, Tokyo, Japan). A mixture of glycerin
and fructose, normal saline, adrenaline, and methylene blue
was injected into the submucosal plane with a submucosal
injection needle (Alton) to create a visible submucosal
cushion for elevation of the lesion. Mucosal incision
and submucosal dissection were performed using the
needle knife or insulated tip knife (Olympus Endoscopy
Medical System, Tokyo, Japan) depending on the indi-
vidual endoscopists’ preference. All procedures were
performed without anesthesia. The patients undergoing
ESD did not receive any kind of IV sedation.
Outcome measurements
Short-term clinical outcomes included operative time,
morbidity rate, time to ambulation, and hospital stay.
Morbidity was defined as any complication that required
reintervention or resulted in prolonged hospital stay.
Bleeding was defined as any bleeding episode during or
after the operation that required blood transfusion. Per-
foration was either identified during the operation or di-
agnosed when free intraperitoneal gas was found on
abdominal imaging after the operation. Acute retention
of urine was defined as failure to void within 24 h after
the operation. Other operative details including the op-
erative time and the en bloc resection rate also were
compared between the two groups.
Methods of postoperative surveillance
We mainly used medical records and nursing records to
get initial postoperative information; we also conformed
these information by telephone follow-up and got more
follow-up data.
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Statistical analysis
Continuous variables were presented as mean (standard
deviation), and dichotomous variables were presented as
number and percentage values. Patients with different
procedures were compared in regard to age, sex, and
pathologic tumor characteristics with Fisher exact test,
chi-square test, or independent t test, as appropriate. All
analyses were performed with SPSS version 17 statistical
software package (SPSS, Inc., Chicago, IL).
Results
The baseline characteristics of the two groups were
shown in Table 1. The two groups did not differ in terms
of age, sex, or distance from anal verge. The mean size
of tumors was significantly bigger in the TALE group
(0.8 ± 0.2 versus 1.1 ± 0.5 cm; P = 0.018). En bloc resec-
tion was achieved for 30 patients (97 %) in the ESD
group and all the patients in the TALE group.
Operative time was longer in the TALE than in the ESD
group (40.0 ± 22.7 min versus 12.2 ± 5.3 min; P < 0.001).
Complications in the TALE group were five cases of
AROU. There were no bleeding or perforation cases
in either group. Table 2 summarizes procedure-related
parameters.
Follow-up data was available in 24 patients in the ESD
group because seven patients were not due for follow-up
at the time of analysis. One patient underwent additional
surgery (TALE) after ESD because the ESD specimen
showed positive resection margin. Follow-up data was
analyzed in 18 patients in the TALE group. The median
follow-up period was 16.4 months (range 8–31 months)
in the ESD group and 28.4 months (range 8–68 months)
in the TALE group. The median number of follow-up
colonoscopies was 1.9 times (range 1–4 times) in the
ESD group and 2.5 times (range 1–5 times) in the
TALE group. There was no local recurrence or distant
metastasis in any patients in either group during the
follow-up period.
Discussion
Rectal carcinoid tumor is a rare condition accounting for
only 1.3 % of the overall rectal tumor cases [10, 11].
Tumor size has been a known prognostic factor for rectal
carcinoid tumors. ESD, TALE, and radical resection have
been performed as treatments of rectal carcinoid tumor.
However, it is currently difficult to decide between treat-
ments such as local excision and radical surgery, especially
for tumors that are >1 to ≤2 cm in diameter. It appears
that small rectal carcinoids <1 cm in size can be safely
managed by local excision. For tumors >1 to ≤2 cm, local
excision is usually recommended, but radical surgery
should be considered if there is evidence of lymph node
metastasis [12]. The preoperative radiological evaluation
of lymph node metastasis was critical. Pelvic imaging
evaluation such as CT or endorectal ultrasound was made,
and no enlarged lymph nodes were found in our patients
before surgery.
ESD and TALE are performed for local excision of
rectal carcinoids in daily clinical work. Which is the
best method for the local resection of rectal carcinoids?
Son et al. reported pathologically determined complete-
resection (P-CR) rates for small rectal carcinoid tumors
excised by using several methods. The P-CR rates were
30.9, 72.0, and 81.8 % for a conventional endoscopic
polypectomy, ESD, and TALE [13]. TALE is a traditional
procedure for treating lower rectal tumors and provides
deeper vertical resection margin. Kim et al. [14] described
the complete-resection rate for transanal surgery as over
97 %. Recently Son et al. reported that the pathologically
complete-resection rates were 30.9, 72.0, and 81.8 % for
conventional polypectomy, advanced endoscopic tech-
niques, and surgical local excision, respectively. Patho-
logically complete-resection of small rectal carcinoid
tumors was more likely to be achieved when using sur-
gical local excision [14]. Ono et al. [15] described re-
sults obtained with 14 rectal carcinoid tumors treated
by ESD between 1999 and 2002. All tumors were com-
pletely resected, and no recurrence was noted at a me-
dian follow-up of 10.5 months. In our study, the mean
tumor size was 1.1 ± 0.5 cm and 0.8 ± 0.2 cm in TALE
and ESD group, respectively. All lesions were confined
to the submucosal layer. The pathologically complete-
resection rates were 97 and 100 % for ESD and TALE,
respectively. The results suggested that pathologically
complete resection of rectal carcinoid tumors can be
Table 1 Demographic data and tumor characteristics for the
TALE and ESD groups
TALE (n = 23) ESD (n = 31) p value
Mean age (years) 47.9 ± 11.7 52.2 ± 10.2 0.159
Sex (male/female) 14/9 22/9 0.436
Tumor size (cm) 1.1 ± 0.5 0.8 ± 0.2 0.018
Distance from anal verge (cm) 5.4 ± 1.5 5.9 ± 2.3 0.435
En bloc resection: n (%) 23 (100 %) 30 (97 %) 1.0
Operation time 40.0 ± 22.7 12.2 ± 5.3 <0.001
Muscular invasion 0 0 /
Lymphovascular invasion 0 0 /
Table 2 Short-term postoperative complications
Procedure AROU Anus ache Bleeding Perforation
TALE 5 16 0 0
ESD 0 3 0 0
p value 0.024 <0.001 / /
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achieved when using proper procedure according to the
tumor size.
However, TALE must be also considered to be more in-
vasive because of the risk associated with the use of
anesthesia [14]. Spinal anesthesia is a risk factor for acute
retention of urine (AROU). In fact, anal dilation or retrac-
tion because of operation may cause anal pain and also
may result in AROU. These factors explain why the TALE
group had a significantly higher incidence of AROU. On
the other hand, ESD is performed without anesthesia, and
there is no need to dilate the anal sphincter. This may ac-
count for the lower morbidity rate and shorter operative
time in the ESD group.
But for a local recurrence case, TALE may be more ap-
propriate. ESD was performed after a mixture of glycerin
and fructose, normal saline, adrenaline, and methylene
blue was injected into the submucosal layer in order to
achieve en bloc resection and avoid perforation. However,
the lesion cannot be lifted after injection because of the
existence of fibrosis in the submucosal layer in the case of
local recurrence. The cut and the dissection steps that use
cutting devices may be technically difficult. Fujishiro et al.
reported that endoscopic en bloc resection was not
achieved in some colorectal tumors because of fibrosis
which prevented a sufficient submucosal fluid cushion
in the submucosal layer [16]. In the TALE group, one
patient had a reoperation because of positive resection
margin with ESD. By TALE procedure, the tumor was
removed with R0 resection. From our opinion, TALE
may be a safe and effective method in the treatment of
scar embedded lesion.
This study had some limitations. First, this was a
retrospective study. We were unable to fully evaluate
possible confounders, owing to the retrospective na-
ture of this study. The second limitation of this study
was that further follow-up studies are required to
more accurately define the long-term outcomes of
TALE and ESD. The third limitation of this study was
the limited presented data and the number of patients
enrolled. It is because the disease incidence is low that
there is a difficulty of achieving an adequate number
of cases for comparative analysis. Best results should
be achieved with work with more patients and prefera-
bly a multicenter.
Conclusion
In conclusion, for the treatment of rectal carcinoid tu-
mors with diameter <1 cm, ESD has better short-term
clinical outcomes than TALE in terms of faster recovery
and possibly a lower morbidity rate. TALE may be the
first therapeutic choice of scar embedded rectal carcin-
oid tumors. Prospective studies with larger samples are
needed to validate the benefits of TALE.
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